Skip to main content
. 2008 Jun;5(6):50–55.

TABLE 1.

Common psychotropic classes causing sexual dysfunction

TRICYCLIC ANTIDEPRESSANTS
Adapted from Crenshaw TL, Goldberg JP. Sexual Pharmacology: Drugs That Affect Sexual Functioning. New York, NY: W. W. Norton & Company, 1996.
      Mechanism of action (general)
  • Inhibits the re-uptake of norepinephrine and serotonin (5-HT)

  • Modulates norephinephrine and 5-HT activity at the neural synapse

      Mechanism of action (sexual)
      Positive
Increased adrenergic α1 activity
Decreased cortisol
       
      Negative
Decreased β–adrenergic activity
Decreased cholinergic activity
Decreased histamine
Decreased oxytocin
Increased prolactin
Increased serotonin
      Direct sexual side effects*
      Desire disorders
Dyspareunia
Erection difficulties
       
      Orgasm disorders
Orgasmic inhibition
Anorgasmia
Spontaneous orgasm
       
      Ejaculation disorders
Retarded ejaculation
Ejaculation without orgasm
Anesthetic ejaculation
MONOAMINE OXIDASE INHIBITORS
      Mechanism of action (general)
  • Decreases the neural monoamine oxidase enzymatic metabolic breakdown of norepinephrine and serotonin I

  • Increases norepinephrine and serotonin activity at the neural synapse

      Mechanism of action (sexual)
      Positive
Increased adrenergic α1 activity
Decreased monoamine oxidase
       
      Negative
Decreased β-adrenergic activity
Decreased cholinergic activity
Increased prolactin
Increased serotonin
Decreased testosterone
      Direct sexual side effects*
      Desire disorders
Erection difficulties
       
      Orgasm disorders
Orgasmic inhibition
Decreased number
       
      Ejaculation disorders
Retarded, inhibited
premature ejaculation
diminished
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
      Mechanism of action (general)
  • Work through selective serotonin-uptake inhibition

      Mechanism of action (sexual)
      Negative
Increased cortisol
Increased opioids
Increased prolactin
Increased serotonin (5-HT)
      Direct sexual side effects
      Desire disorders
Hyposexuality
Hypersexuality
       
      Orgasm disorders
Orgasmic inhibition
Anorgasmia
Spontaneous orgasm
       
      Ejaculation disorders
Retarded ejaculation
Ejaculatory inhibition
       
      Erection disorders
Inability/difficulty obtaining erection
Decreased quality of erection
Decreased or absent nocturnal/morning erections
ANTIPSYCHOTICS
      Mechanism of action (general)
  • Block dopamine activity

  • Block sigma receptors and/or 5-HT2 serotonin receptors

      Mechanism of action (sexual)
      Negative
Decreased adrenergic ·1 activity
Decreased cholinergic activity
Decreased dopamine
Increased prolactin
Decreased testosterone
Decreased LHRH pulsatile activity
      Direct sexual side effects
      Desire disorders
Hyposexuality
Hypersexuality (rare)
       
      Orgasm disorders
Orgasmic inhibition
Anorgasmia
Diminished number of orgasms
       
      Ejaculation disorders
Retarded ejaculation
Ejaculatory inhibition
Decreased ejaculatory volume
Anesthetic ejaculation
Orgasm without ejaculation
Dyspareunia
       
       Erection disorders
Inability/difficulty obtaining erection
Decreased quality of erection
Priapism

* Despiramine appears to have the least amount of sexual side effects of the TCAs